Used in neuroscience and clinical research to quantify glial fibrillary acidic protein (GFAP) levels in biological samples such as serum, plasma, or tissue homogenates. It serves as a biomarker for astrocyte activation and damage, commonly applied in studies of traumatic brain injury, stroke, neurodegenerative diseases like Alzheimer's, and neuroinflammation. The kit enables high-throughput, sensitive detection of GFAP, supporting both diagnostic development and monitoring of disease progression in research settings. It is widely used in pharmaceutical and academic laboratories to evaluate central nervous system injury and response to therapeutic interventions.